Jaguar Health Inc
JAGXLatest QuantConomy context for JAGX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Jaguar Health Inc
QuantConomy has a structured record for JAGX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- JAGX
- Name
- Jaguar Health Inc
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq
Recent signals for JAGX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| other event | neutral | 70 | Jul 1, 08:55 PM | JAGX filed 8-K: Other Events - 1 material event - [strong neutral signal] |
| revenue change | very bearish | 76 | May 20, 12:00 AM | JAGX (Q1 2026, revenue): declined 91.7% ($11.00M → $918.00K). [sequential period basis, very bearish signal] |
| eps change | very bullish | 73 | May 20, 12:00 AM | JAGX (Q1 2026, diluted eps): EPS grew 40.8% ($-22.97 → $-13.60). [sequential period basis, very bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| JAGX | NASDAQ | alphavantage | Jaguar Health Inc |
| JAGX | NASDAQ | alpaca | Jaguar Health, Inc. Common Stock |
| JAGX | NASDAQ | fmp | Jaguar Health, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | BOCHNOWSKI JAMES J | Insider | grant | 6,363 | $0.00 | $0 | 4 on EDGAR |
| Dec 11, 2025 | King Steven R. | See Remarks | grant | 11,740 | $0.00 | $0 | 4 on EDGAR |
| Dec 11, 2025 | Jayasuriya Anula | Insider | grant | 5,870 | $0.00 | $0 | 4 on EDGAR |
| Dec 11, 2025 | Wolin Jonathan S. | See Remarks | grant | 11,740 | $0.00 | $0 | 4 on EDGAR |
| Dec 11, 2025 | Lizak Carol R. | Chief Financial Officer | grant | 11,740 | $0.00 | $0 | 4 on EDGAR |
| Dec 11, 2025 | Siegel Jonathan B. | Insider | grant | 7,377 | $0.00 | $0 | 4 on EDGAR |
| Dec 11, 2025 | CONTE LISA A | See Remarks | grant | 28,592 | $0.00 | $0 | 4 on EDGAR |
| Dec 11, 2025 | Chaturvedi Pravin R | Chief Scientific Officer | grant | 11,740 | $0.00 | $0 | 4 on EDGAR |
| Dec 11, 2025 | MICEK JOHN | Director | grant | 7,377 | $0.00 | $0 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query JAGX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access